Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
MariMed Inc. (MRMD) generates frequent news as a multi-state cannabis operator and cannabis consumer packaged goods company focused on branded products, facility operations, and regulatory developments. Its releases cover both corporate performance and brand-level activity across cultivation, production, and retail channels.
On this page, readers can follow MariMed’s earnings announcements, where the company discusses revenue trends, gross margins, net income or loss, and non-GAAP measures such as Adjusted EBITDA. These updates often include commentary on wholesale and retail performance, as well as progress on what management calls its "Expand the Brand" strategy to grow top-selling cannabis brands.
MariMed’s news flow also highlights product and brand developments. Examples include new limited-edition Betty’s Eddies™ fruit chews, extensions to the Nature’s Heritage™ product line, and initiatives for Vibations™ and InHouse™. The company reports on licensing and managed services agreements that bring its brands into additional states, as well as strategic decisions such as exiting specific markets after operational reviews.
In addition, MariMed issues releases on community and veteran-focused initiatives tied to its Thrive dispensaries and brands, along with commentary on major policy changes affecting cannabis, such as the rescheduling of cannabis at the federal level. Investors and observers can use this news feed to monitor how MariMed communicates its strategy, brand expansion, financial performance, and responses to regulatory and market changes over time.
Summary not available.
MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced it will release its third quarter 2021 financial results on November 15, 2021, after market close. Management will hold a conference call on November 16, 2021, at 8:00 a.m. EDT to discuss these results. The call will be accessible via the company's Investor Relations website, with a playback available for 30 days. MariMed is focused on providing high-quality cannabis products and has developed a robust portfolio, including brands like Betty's Eddies® and Nature’s Heritage™.
MariMed, Inc. (OTCQX: MRMD) announced the appointment of Steve West as Vice President of Investor Relations. With nearly 20 years of experience, West has held significant roles at renowned companies like Neptune Wellness Solutions and Acreage Holdings. He is recognized for his expertise in investor relations, previously serving as a successful sell-side analyst. His military background includes over 14 years in the U.S. Navy. This strategic appointment aims to enhance MariMed's communication with capital markets and strengthen investor relations.
MariMed, Inc. (OTCQX: MRMD) announced health and safety protocols for its annual meeting on September 23, 2021, at Hilton Boston/Dedham. Only stockholders will be admitted, with record stockholders confirmed from company records. Attendees must present proof of vaccination or a negative COVID-19 test within 72 hours. Masks are mandatory, and no food or beverages are allowed. The company focuses on health and wellness in the cannabis sector, managing state-licensed facilities and producing award-winning products such as Betty's Eddies® and Nature’s Heritage™.
MariMed, Inc. (OTCQX: MRMD) has launched new SKUs of its popular Betty’s Eddies cannabis-infused fruit chews, introducing single-serving options and multi-packs after customer requests. The single-serving packs aim to enhance trial among new consumers and facilitate impulse purchases. Multi-packs will feature an assortment of classic flavors, allowing users to explore different options. Betty’s Eddies chews are made with full-spectrum cannabis oil and organic ingredients, and are already the leading cannabis edible in Maryland and Massachusetts.
MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced its participation in several upcoming conferences. CEO Bob Fireman will present at the Cannabis Virtual Investor Conference on September 8th and the Echelon Capital Markets U.S. MSO Cannabis Conference on September 22nd. Additionally, management will hold one-on-one meetings at the Beacon Securities Virtual Cannabis Conference on September 9th. Fireman will also participate in a panel discussion at the Burns Levinson Conference on September 28th. MariMed is dedicated to high-quality cannabis products and has shown consistent growth.
MariMed Inc. (MRMD:OTCQX) has announced key appointments to enhance its brand and marketing strategies. Robert Hall, former CMO of Sam Adams, joins as Senior Brand and Marketing Advisor, focusing on brand strategy and team expansion. Kevin Compagna takes on the role of VP, Wholesale & Licensing, tasked with increasing revenues and market share for top products like Betty’s Eddies and Nature’s Heritage. The company's management emphasizes a strategic plan aimed at maximizing revenue potential while maintaining operational efficiency.
MariMed, a multi-state cannabis operator, announced a collaboration with Emack & Bolio’s to launch a line of cannabis-infused vegan and dairy ice creams. Utilizing MariMed’s formulations rich in cannabinoids and terpenes, the products are set to debut in Massachusetts before expanding to other legal markets. This partnership aims to leverage the growing trend in the ice cream market towards healthier options, as noted by Mordor Intelligence, which projects a 3% growth driven by demand for natural ingredients.
MariMed Inc. (MRMD:OTCQX) announced that CEO Bob Fireman will speak at the Benzinga Virtual Cannabis Capital Conference on October 15th. The conversation will address the company’s revenue growth in the Massachusetts and Illinois cannabis markets and its consolidation strategy. Additionally, MariMed management will hold one-on-one meetings with institutional investors to discuss its growth strategy amid evolving regulations. Interested investors can register for the event online.
MariMed develops state-licensed cannabis facilities and industry-leading products, focused on health and wellness.
MariMed Inc. (MRMD:OTCQX) has launched a new line of solventless concentrates under its Nature’s Heritage brand, specifically live rosin. This product is designed to appeal to cannabis consumers seeking high-quality, flavor-rich options. With a focus on meeting strong consumer demand, the company aims to enhance its market share and revenue through this ultra-premium offering. The brand has established itself as a top flower seller in Massachusetts and Maryland, now expanding its product line to include various concentrates and other cannabis products. Visit Nature’s Heritage for more information.